On 2/26/25, United Therapeutics Corp (NASDAQ: UTHR) stock suffered a major decline of -10.8%, closing at $318.89. Moreover, this decline was accompanied by exceptionally high trading volume at 435% of normal. The stock has declined -14.5% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
United Therapeutics has a current Value Trend Rating of B (Positive). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. United Therapeutics has a slightly positive Power Rating of 68 and a good Appreciation Score of 70, resulting in the Positive Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment